MDM2 Gene Accelerated Tumor Formation Susceptibility to NGS Genetic DNA Test
Introduction
The MDM2 Gene Accelerated Tumor Formation Susceptibility to NGS Genetic DNA Test is designed to evaluate an individual’s genetic predisposition to tumor formation. This test employs Next-Generation Sequencing (NGS) technology, which allows for a comprehensive analysis of the MDM2 gene, a critical factor in regulating cell growth and division. Understanding your genetic makeup is vital for early detection and intervention strategies in cancer management.
What the Test Measures
This genetic test specifically measures variations in the MDM2 gene that may indicate an increased risk of developing tumors. By analyzing the genetic code, healthcare providers can assess the susceptibility to certain types of cancers, enabling informed decisions regarding monitoring and preventative measures.
Who Should Consider This Test
Individuals with a family history of cancer, particularly those with known MDM2 gene mutations, should consider this test. Symptoms such as unexplained weight loss, persistent fatigue, or unusual lumps may also warrant testing. Additionally, individuals with risk factors, such as a hereditary cancer syndrome, are encouraged to undergo this genetic evaluation.
Benefits of Taking the Test
- Early detection of potential cancer risks.
- Informed decision-making regarding health management.
- Personalized healthcare strategies based on genetic insights.
- Access to genetic counseling for better understanding and support.
Understanding Your Results
Results from the MDM2 Gene Accelerated Tumor Formation Susceptibility to NGS Genetic DNA Test will be provided in a comprehensive report. Patients will receive guidance on interpreting their results and recommendations for further action, if necessary. It is essential to discuss these results with a healthcare provider to understand their implications fully.
Test Name and Price
| Test Name | Discount Price | Regular Price |
|---|---|---|
| MDM2 Gene Accelerated Tumor Formation Susceptibility to NGS Genetic DNA Test | 40,000 KSh | 56,000 KSh |
Branches and Booking
We have branches across all major cities in Kenya, including Nairobi, Mombasa, and Kisumu, making it convenient for you to access our services. We also offer home sample collection services for your convenience.
To book the MDM2 Gene Accelerated Tumor Formation Susceptibility to NGS Genetic DNA Test, please call or WhatsApp us at +254711564616 today!
Pre-Test Instructions
Before undergoing the test, a genetic counseling session is recommended to draw a pedigree chart of family members affected by MDM2 Gene Accelerated Tumor Formation. It is essential to provide a clinical history to ensure accurate results.
Turnaround Time and Sample Type
The expected turnaround time for results is 3 to 4 weeks. Samples can be collected as blood, extracted DNA, or one drop of blood on an FTA card.
